Skip to main content

Table 4 Prevalence of sarcopenia and sarcopenia categories according to CKD-EPI eGFR (ml/min/1.73m2) categories

From: Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria

 

Non-sarcopenic (n = 1270)

Sarcopenic (n = 150)

p-value

CKD-EPI eGFR category

No sarcopenia (n = 1114)

Probable sarcopenia (n = 156)

Confirmed sarcopenia (n = 65)

Severe sarcopenia (n = 85)

≥90 (n = 42)

37 (88.1%)

5 (11.9%)

0.774

29 (69.0%)

8 (19.0%)

3 (7.1%)

2 (4.8%)

 

60–89 (n = 884)

795 (89.9%)

89 (10.1%)

0.435

720 (81.4%)

75 (8.5%)

46 (5.2%)

43 (4.9%)

 

45–59 (n = 247)

226 (91.5%)

21 (8.5%)

0.246

194 (78.5%)

32 (13.0%)

5 (2.0%)

16 (6.5%)

 

30–44 (n = 163)

139 (85.3%)

24 (14.7%)

0.066

112 (68.7%)

27 (16.6%)

9 (5.5%)

15 (9.2%)

 

15–29 (n = 84)

73 (86.9%)

11 (13.1%)

0.436

59 (70.2%)

14 (16.7%)

2 (2.4%)

9 (10.7%)

 

≥60 (n = 1173)

1058 (90.2%)

115 (9.8%)

0.042

943 (80.4%)

115 (9.8%)

54 (4.6%)

61 (5.2%)

< 60 (n = 247)

212 (85.8%)

35 (14.2%)

171 (69.2%)

41 (16.6%)

11 (4.5%)

24 (9.7%)

  1. CKD-EPI Chronic Kidney Disease Epidemiological Collaboration, eGFR Estimated glomerular filtration rate